Companies: 10,795·Total market cap: $144.5T
Beleave Inc.

Beleave Inc.

BLEVFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$566
P/E Ratio
52W High$0.0001
52W Low$0.000001
Overview

Beleave Inc. (BLEVF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

BLEVF · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
409.2M +71.02% YoY Change
FY · as of Mar 31, 2019 · Reported in CAD
vs 239.3M in FY 2018
Diluted Shares Outstanding
409.2M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+71.02%
year-over-year
Float (Free Float)
547.3M
publicly tradable shares
96.7% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+61.7%
2016 → 2019
5-Year CAGRincreasing
+37.7%
2014 → 2019
10-Year CAGRincreasing
+15.0%
2009 → 2019

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2019Latest
Diluted Shares: 409.2M
409.2M
+71.02%
FY 2018
Diluted Shares: 239.3M
239.3M
+58.55%
FY 2017
Diluted Shares: 150.9M
150.9M
+56.04%
FY 2016
Diluted Shares: 96.7M
96.7M
+9.84%
FY 2015
Diluted Shares: 88.1M
88.1M
+6.37%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs BLEVF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+511.4%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+493.5%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+335.1%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+278.8%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+122.4%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+119.4%
#7
Beleave Inc.BLEVF
Beleave Inc.YOU
409.2M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Beleave Inc. (BLEVF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of March 31, 2019, Beleave Inc. reports 409.2M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Beleave Inc.'s basic shares outstanding (409.2M) represents currently issued shares. Diluted shares outstanding (409.2M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Beleave Inc.'s float is 547.3M (96.7% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float547.3M(96.7%)
Outstanding566.0M

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · CAD

About shares outstanding & methodology

Beleave Inc. (BLEVF) shares outstanding history from 2001 to 2019. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Beleave Inc. shares outstanding for the fiscal year ending March 31, 2019 were 409.2M, a 71.02% increase year-over-year. Beleave Inc. FY 2019 shares outstanding were 409.2M, a +71.02% increase from FY 2018.

Beleave Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +15.0% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

BLEVF shares outstanding · 4 questions

As of March 31, 2019, Beleave Inc. (BLEVF) has approximately 409.2M basic shares outstanding and 409.2M diluted shares outstanding. This represents a +71.02% year-over-year increase from FY 2018 (239.3M). The increase may reflect equity compensation issuances or secondary offerings.

BLEVF shares outstandinghow many shares does BLEVF haveBLEVF basic shares 2019BLEVF diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Beleave Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09